FDA Guidance for Industry: Q13 CONTINUOUS MANUFACTURING OF DRUG SUBSTANCES AND DRUG PRODUCTS
Title:
FDA Guidance for Industry: Q13 CONTINUOUS MANUFACTURING OF DRUG
SUBSTANCES AND DRUG PRODUCTS
Origin/Publisher:
FDA
Content:
This guideline describes scientific and regulatory considerations for the development, implementation, operation, and lifecycle management of continuous manufacturing (CM).